Skip to main content

Table 5 drug toxicity and adverse events

From: Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients

Adverse events No toxicity (grade0–2)
(N = 109)
Toxicity(grade 3–4)
(N = 102)
Hematological
 Leucopenia 98 95
 Neutropenia 93 90
 Anemia 8 1
 Thrombocytopenia 2 1
Gastrointestinal
 Nausea 47 0
 Vomiting 86 18
 Diarrhea 16 13
Skin rash 6 2
hepatotoxicity 3 0
Renal toxicity 1 0